Cardiff Oncology Inc. buy BiotechBee
Start price
29.04.24
/
50%
€4.28
Target price
31.07.26
€5.00
Performance (%)
-34.62%
Price
04.06.24
€2.80
Summary
This prediction is currently active. Massive losses of -34.62% have been the result for the BUY prediction by BiotechBee. This prediction currently runs until 31.07.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cardiff Oncology Inc. | -6.208% | -6.208% |
iShares Core DAX® | -1.042% | 2.220% |
iShares Nasdaq 100 | -1.361% | 3.207% |
iShares Nikkei 225® | -0.044% | -1.680% |
iShares S&P 500 | -0.480% | 2.165% |
According to BiotechBee what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Trovagene diskutieren
Buy mit Kursziel 5,0